Reevaluating Beta Blockers' Role in Heart Attack Treatment
The REBOOT trial found that beta blockers, a standard treatment for heart attack patients with preserved heart function, offer no significant benefit and may increase risks for women, potentially leading to a change in clinical guidelines worldwide.